About Coeur Inc
Coeur Inc is a Healthcare company based in Lebanon (United States) founded in 2003, and was acquired by Illinois Tool Works in July 2013. Single-use, disposable products for the imaging market. The company was acqui-hired. Its focus areas include Life Sciences, Drug Delivery and Intravenous. Its competitors include Insulet, Lyra Therapeutics and TriSalus Life Sciences; 3 of its 3 listed competitors have raised funding.
Company details
Coeur focuses on the manufacturing of single-use, disposable products for the imaging market. The company has developed CT and Angiographic power syringes and fluid delivery products, such as the Liebel-Flarsheim and MEDRAD injectors. The company received FDA 510(k) clearance in August 2017 (K170431) for its CT Syringe For Stellant Injectors (With Without Spikes, Prime Tubes, Fill Tubes), CT Syringe Dual Pack For Stellant Injectors (With Without Spikes, Prime Tubes, Fill Tubes), Single Fascia And Ram Tip, Dual Fascia And Ram Tip.
- Headquarters Lebanon, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website coeurinc.com
- Social LinkedIn
- Acquired by Riverside (Oct 2008)
- InvestorsIllinois Tool Works
& 1 more
- Acquired by
Investors in Coeur Inc
Coeur Inc has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Illinois Tool Works and The Riverside Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt are provided to middle market companies. | riversidecompany.com | Cleveland, United States | ||
Major auto components are manufactured and supplied to OEMs. | 1912 | itw.com | Glenview, United States |
Investor details for Coeur Inc
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Coeur Inc
3 dated milestones of Coeur Inc across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Coeur Inc is founded.
- Exit Acquired by Riverside.
- Exit Acquired by Illinois Tool Works.
Competitors of Coeur Inc
Coeur Inc has 3 listed competitors in our database, 3 of them funded. They include Insulet, Lyra Therapeutics and TriSalus Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insulet.com | 2000 | Boston, United States | $120.4M | 2,600 | Wearable insulin infusion systems are developed for diabetes patients. | |
| lyratherapeutics.com | 2005 | Watertown, United States | $127.61M | 75 | Small molecule therapeutics for ENT diseases are developed. | |
| trisaluslifesci.com | 2009 | Westminster, United States | $83.37M | 100 | Developer of drug delivery devices to treat cancers |
Detailed competitors of Coeur Inc
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Coeur Inc (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Coeur Inc
Coeur Inc was founded in 2003.
Coeur Inc is headquartered in Lebanon, United States.
Coeur focuses on the manufacturing of single-use, disposable products for the imaging market. The company has developed CT and Angiographic power syringes and fluid delivery products, such as the Liebel-Flarsheim and MEDRAD injectors. The company received FDA 510(k) clearance in August 2017 (K170431) for its CT Syringe For Stellant Injectors (With Without Spikes, Prime Tubes, Fill Tubes), CT Syringe Dual Pack For Stellant Injectors (With Without Spikes, Prime Tubes, Fill Tubes), Single Fascia And Ram Tip, Dual Fascia And Ram Tip.
Coeur Inc's top competitors include Insulet, Lyra Therapeutics and TriSalus Life Sciences.
Coeur Inc has 2 investors. Key investors include Illinois Tool Works, and The Riverside Company.
Yes. Coeur Inc was acquired by Riverside in October 2008.